Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+15.63%)
At close: Nov 16, 2026 · 4:00 PM EST

Elite Pharmaceuticals (ELTP) Ending Cash Balance (2009 - 2026)

Updated

Elite Pharmaceuticals (ELTP) reported Ending Cash Balance of $35.34 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 30.5% from $27.08 million a year earlier but down 10.3% from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Ending Cash Balance (2009 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals posted Ending Cash Balance of $30.27 million, up 157.2% from FY2025.

  • Ending Cash Balance has a five-year compound annual growth rate of 53.1% (FY2021 to FY2026).
  • By fiscal year, Ending Cash Balance came in at $11.77 million in FY2025 (+56.1%), $7.54 million in FY2024 (-8.6%), $8.24 million in FY2023 (-7.8%) and $8.94 million in FY2022 (+148.5%).
  • Five-year quarterly Ending Cash Balance spans a low of $6.24 million in fiscal Q3 2024 and a high of $39.42 million in fiscal Q1 2027.
  • Year over year, Ending Cash Balance has now increased in each of the last nine quarters, with growth averaging 103.7% over the last eight quarters.
  • The high point for year-over-year Ending Cash Balance in five years was fiscal Q1 2023 (growth of 291.5%); the low point was fiscal Q3 2024 (a decline of 65.9%).
  • Per Business Quant data, the three fiscal quarters before Q2 2027 came in at $39.42 million (Q1 2027), $30.27 million (Q4 2026) and $21.56 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 16.91 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 10.77 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 9.65 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 7.94 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 6.44 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 1.88 Bn
10 Elite Pharmaceuticals 401.23 Mn 274.64 Mn 15.99 Mn 35.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 35.34 Mn
Jun 30, 2026 39.42 Mn
Mar 31, 2026 30.27 Mn
Dec 31, 2025 21.56 Mn
Sep 30, 2025 27.08 Mn
Jun 30, 2025 22.20 Mn
Mar 31, 2025 11.77 Mn
Dec 31, 2024 8.74 Mn
Sep 30, 2024 10.00 Mn
Jun 30, 2024 8.85 Mn
Mar 31, 2024 7.54 Mn
Dec 31, 2023 6.24 Mn
Sep 30, 2023 9.08 Mn
Jun 30, 2023 9.49 Mn
Mar 31, 2023 8.24 Mn
Dec 31, 2022 18.31 Mn
Sep 30, 2022 18.96 Mn
Jun 30, 2022 20.18 Mn
Mar 31, 2022 8.94 Mn
Dec 31, 2021 7.69 Mn
API Access

Elite Pharmaceuticals Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=ELTP&period=max&api_key=YOUR_API_KEY